rs1863703

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015690.5(STK36):​c.884A>G​(p.Lys295Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.071 in 1,614,022 control chromosomes in the GnomAD database, including 7,694 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 2851 hom., cov: 32)
Exomes 𝑓: 0.064 ( 4843 hom. )

Consequence

STK36
NM_015690.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.88

Publications

27 publications found
Variant links:
Genes affected
STK36 (HGNC:17209): (serine/threonine kinase 36) This gene encodes a member of the serine/threonine kinase family of enzymes. This family member is similar to a Drosophila protein that plays a key role in the Hedgehog signaling pathway. This human protein is a positive regulator of the GLI zinc-finger transcription factors. Knockout studies of the homologous mouse gene suggest that defects in this human gene may lead to congenital hydrocephalus, possibly due to a functional defect in motile cilia. Because Hedgehog signaling is frequently activated in certain kinds of gastrointestinal cancers, it has been suggested that this gene is a target for the treatment of these cancers. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2011]
STK36 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ciliary dyskinesia, primary, 46
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0037926435).
BP6
Variant 2-218679665-A-G is Benign according to our data. Variant chr2-218679665-A-G is described in ClinVar as [Benign]. Clinvar id is 1280618.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.353 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STK36NM_015690.5 linkc.884A>G p.Lys295Arg missense_variant Exon 8 of 27 ENST00000295709.8 NP_056505.2 Q9NRP7-1A0A140VJW1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STK36ENST00000295709.8 linkc.884A>G p.Lys295Arg missense_variant Exon 8 of 27 1 NM_015690.5 ENSP00000295709.3 Q9NRP7-1
STK36ENST00000392105.7 linkc.884A>G p.Lys295Arg missense_variant Exon 8 of 27 1 ENSP00000375954.3 Q9NRP7-2
STK36ENST00000440309.5 linkc.884A>G p.Lys295Arg missense_variant Exon 8 of 27 5 ENSP00000394095.1 Q9NRP7-1
STK36ENST00000424080.1 linkc.*48A>G downstream_gene_variant 5 ENSP00000403527.1 C9JDA4

Frequencies

GnomAD3 genomes
AF:
0.141
AC:
21481
AN:
152018
Hom.:
2839
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.357
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.0838
Gnomad ASJ
AF:
0.0634
Gnomad EAS
AF:
0.0764
Gnomad SAS
AF:
0.0552
Gnomad FIN
AF:
0.0374
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.0561
Gnomad OTH
AF:
0.136
GnomAD2 exomes
AF:
0.0779
AC:
19566
AN:
251286
AF XY:
0.0723
show subpopulations
Gnomad AFR exome
AF:
0.369
Gnomad AMR exome
AF:
0.0510
Gnomad ASJ exome
AF:
0.0617
Gnomad EAS exome
AF:
0.0769
Gnomad FIN exome
AF:
0.0443
Gnomad NFE exome
AF:
0.0583
Gnomad OTH exome
AF:
0.0763
GnomAD4 exome
AF:
0.0636
AC:
93010
AN:
1461886
Hom.:
4843
Cov.:
32
AF XY:
0.0628
AC XY:
45665
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.377
AC:
12636
AN:
33480
American (AMR)
AF:
0.0534
AC:
2388
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0646
AC:
1689
AN:
26136
East Asian (EAS)
AF:
0.0664
AC:
2637
AN:
39700
South Asian (SAS)
AF:
0.0566
AC:
4882
AN:
86258
European-Finnish (FIN)
AF:
0.0444
AC:
2372
AN:
53418
Middle Eastern (MID)
AF:
0.103
AC:
593
AN:
5768
European-Non Finnish (NFE)
AF:
0.0546
AC:
60724
AN:
1112008
Other (OTH)
AF:
0.0843
AC:
5089
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
5259
10518
15778
21037
26296
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2436
4872
7308
9744
12180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.142
AC:
21544
AN:
152136
Hom.:
2851
Cov.:
32
AF XY:
0.137
AC XY:
10160
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.357
AC:
14808
AN:
41436
American (AMR)
AF:
0.0838
AC:
1281
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0634
AC:
220
AN:
3470
East Asian (EAS)
AF:
0.0766
AC:
396
AN:
5170
South Asian (SAS)
AF:
0.0557
AC:
269
AN:
4832
European-Finnish (FIN)
AF:
0.0374
AC:
397
AN:
10614
Middle Eastern (MID)
AF:
0.163
AC:
48
AN:
294
European-Non Finnish (NFE)
AF:
0.0561
AC:
3815
AN:
68012
Other (OTH)
AF:
0.136
AC:
286
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
809
1618
2427
3236
4045
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0829
Hom.:
3374
Bravo
AF:
0.155
TwinsUK
AF:
0.0566
AC:
210
ALSPAC
AF:
0.0618
AC:
238
ESP6500AA
AF:
0.351
AC:
1548
ESP6500EA
AF:
0.0565
AC:
486
ExAC
AF:
0.0847
AC:
10282
Asia WGS
AF:
0.0860
AC:
297
AN:
3478
EpiCase
AF:
0.0620
EpiControl
AF:
0.0649

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
16
DANN
Benign
0.97
DEOGEN2
Benign
0.10
T;.;T
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.78
.;T;T
MetaRNN
Benign
0.0038
T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.9
L;L;L
PhyloP100
1.9
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.18
N;N;N
REVEL
Benign
0.035
Sift
Benign
0.44
T;T;T
Sift4G
Benign
0.66
T;T;T
Polyphen
0.056
B;B;B
Vest4
0.066
MPC
0.14
ClinPred
0.014
T
GERP RS
3.0
Varity_R
0.029
gMVP
0.24
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1863703; hg19: chr2-219544388; COSMIC: COSV99831077; API